IBDEI0OM ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11501,1,3,0)
 ;;=3^Myopathy,Alcoholic
 ;;^UTILITY(U,$J,358.3,11501,1,4,0)
 ;;=4^G72.1
 ;;^UTILITY(U,$J,358.3,11501,2)
 ;;=^5004096
 ;;^UTILITY(U,$J,358.3,11502,0)
 ;;=G72.81^^47^533^95
 ;;^UTILITY(U,$J,358.3,11502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11502,1,3,0)
 ;;=3^Myopathy,Critical Illness
 ;;^UTILITY(U,$J,358.3,11502,1,4,0)
 ;;=4^G72.81
 ;;^UTILITY(U,$J,358.3,11502,2)
 ;;=^328484
 ;;^UTILITY(U,$J,358.3,11503,0)
 ;;=G72.0^^47^533^96
 ;;^UTILITY(U,$J,358.3,11503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11503,1,3,0)
 ;;=3^Myopathy,Drug-Induced
 ;;^UTILITY(U,$J,358.3,11503,1,4,0)
 ;;=4^G72.0
 ;;^UTILITY(U,$J,358.3,11503,2)
 ;;=^5004095
 ;;^UTILITY(U,$J,358.3,11504,0)
 ;;=G72.41^^47^533^97
 ;;^UTILITY(U,$J,358.3,11504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11504,1,3,0)
 ;;=3^Myopathy,Inclusion Body Myositis
 ;;^UTILITY(U,$J,358.3,11504,1,4,0)
 ;;=4^G72.41
 ;;^UTILITY(U,$J,358.3,11504,2)
 ;;=^5004098
 ;;^UTILITY(U,$J,358.3,11505,0)
 ;;=G72.49^^47^533^98
 ;;^UTILITY(U,$J,358.3,11505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11505,1,3,0)
 ;;=3^Myopathy,Inflammatory/Immune NEC
 ;;^UTILITY(U,$J,358.3,11505,1,4,0)
 ;;=4^G72.49
 ;;^UTILITY(U,$J,358.3,11505,2)
 ;;=^5004099
 ;;^UTILITY(U,$J,358.3,11506,0)
 ;;=G72.2^^47^533^99
 ;;^UTILITY(U,$J,358.3,11506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11506,1,3,0)
 ;;=3^Myopathy,Other Toxic Agents
 ;;^UTILITY(U,$J,358.3,11506,1,4,0)
 ;;=4^G72.2
 ;;^UTILITY(U,$J,358.3,11506,2)
 ;;=^5004097
 ;;^UTILITY(U,$J,358.3,11507,0)
 ;;=G72.3^^47^533^100
 ;;^UTILITY(U,$J,358.3,11507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11507,1,3,0)
 ;;=3^Myopathy,Periodic Paralysis
 ;;^UTILITY(U,$J,358.3,11507,1,4,0)
 ;;=4^G72.3
 ;;^UTILITY(U,$J,358.3,11507,2)
 ;;=^335326
 ;;^UTILITY(U,$J,358.3,11508,0)
 ;;=G72.9^^47^533^101
 ;;^UTILITY(U,$J,358.3,11508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11508,1,3,0)
 ;;=3^Myopathy,Unspec
 ;;^UTILITY(U,$J,358.3,11508,1,4,0)
 ;;=4^G72.9
 ;;^UTILITY(U,$J,358.3,11508,2)
 ;;=^5004101
 ;;^UTILITY(U,$J,358.3,11509,0)
 ;;=M60.9^^47^533^102
 ;;^UTILITY(U,$J,358.3,11509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11509,1,3,0)
 ;;=3^Myositis,Unspec
 ;;^UTILITY(U,$J,358.3,11509,1,4,0)
 ;;=4^M60.9
 ;;^UTILITY(U,$J,358.3,11509,2)
 ;;=^5012409
 ;;^UTILITY(U,$J,358.3,11510,0)
 ;;=M79.2^^47^533^103
 ;;^UTILITY(U,$J,358.3,11510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11510,1,3,0)
 ;;=3^Neuralgia & Neuritis,Unspec
 ;;^UTILITY(U,$J,358.3,11510,1,4,0)
 ;;=4^M79.2
 ;;^UTILITY(U,$J,358.3,11510,2)
 ;;=^5013322
 ;;^UTILITY(U,$J,358.3,11511,0)
 ;;=M54.81^^47^533^104
 ;;^UTILITY(U,$J,358.3,11511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11511,1,3,0)
 ;;=3^Neuralgia,Occipital
 ;;^UTILITY(U,$J,358.3,11511,1,4,0)
 ;;=4^M54.81
 ;;^UTILITY(U,$J,358.3,11511,2)
 ;;=^5012312
 ;;^UTILITY(U,$J,358.3,11512,0)
 ;;=M89.70^^47^533^106
 ;;^UTILITY(U,$J,358.3,11512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11512,1,3,0)
 ;;=3^Osseous Defect,Major,Unspec Site
 ;;^UTILITY(U,$J,358.3,11512,1,4,0)
 ;;=4^M89.70
 ;;^UTILITY(U,$J,358.3,11512,2)
 ;;=^5015085
 ;;^UTILITY(U,$J,358.3,11513,0)
 ;;=M79.81^^47^533^105
 ;;^UTILITY(U,$J,358.3,11513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11513,1,3,0)
 ;;=3^Nontraumatic Hematoma,Soft Tissue
 ;;^UTILITY(U,$J,358.3,11513,1,4,0)
 ;;=4^M79.81
 ;;^UTILITY(U,$J,358.3,11513,2)
 ;;=^5013356
 ;;^UTILITY(U,$J,358.3,11514,0)
 ;;=M88.9^^47^533^107
 ;;^UTILITY(U,$J,358.3,11514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11514,1,3,0)
 ;;=3^Osteitis Deformans,Unspec Bone
